What is Celldex Therapeutics' stock symbol?
Celldex Therapeutics trades on the NASDAQ under the ticker symbol "CLDX."
Where is Celldex Therapeutics' stock going? Where will Celldex Therapeutics' stock price be in 2017?
11 brokers have issued 12-month price objectives for Celldex Therapeutics' shares. Their predictions range from $3.00 to $16.00. On average, they expect Celldex Therapeutics' stock price to reach $7.75 in the next year.
When will Celldex Therapeutics announce their earnings?
Celldex Therapeutics is scheduled to release their next quarterly earnings announcement on Tuesday, March, 14th 2017.
Who owns Celldex Therapeutics stock?
Celldex Therapeutics' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include FMR LLC (19.09%), KLP Enterprises LLC (6.78%), Franklin Resources Inc. (6.16%), Columbia Wanger Asset Management LLC (6.12%), State Street Corp (4.27%) and Frontier Capital Management Co. LLC (1.55%). Company insiders that own Celldex Therapeutics stock include Anthony S Marucci, Avery W Catlin, Larry Ellberger and Tibor Keler.
Who sold Celldex Therapeutics stock? Who is selling Celldex Therapeutics stock?
Celldex Therapeutics' stock was sold by a variety of institutional investors in the last quarter, including RTW Investments LP, Numeric Investors LLC, State Street Corp, Franklin Resources Inc., Renaissance Technologies LLC, Frontier Capital Management Co. LLC, Metropolitan Life Insurance Co. NY and National Planning Corp.
Who bought Celldex Therapeutics stock? Who is buying Celldex Therapeutics stock?
Celldex Therapeutics' stock was bought by a variety of institutional investors in the last quarter, including KLP Enterprises LLC, FMR LLC, Columbia Wanger Asset Management LLC, Deerfield Management Co., A.R.T. Advisors LLC, Russell Investments Group Ltd., Federated Investors Inc. PA and Paulson & CO. Inc.. Company insiders that have bought Celldex Therapeutics stock in the last two years include Anthony S Marucci, Larry Ellberger and Tibor Keler.
How do I buy Celldex Therapeutics stock?
Shares of Celldex Therapeutics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Celldex Therapeutics stock cost?
One share of Celldex Therapeutics stock can currently be purchased for approximately $3.26.